Scarica l'app Stockscreener
56.68
3.54%
1.94
Dopo l'orario di chiusura:
56.68
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Bio Techne Corp Borsa (TECH) Ultime notizie
Bio-Techne Corp. stock outperforms competitors on strong trading day - MarketWatch
Bio-Techne (TECH) executive nets shares from 794 RSU exercise - Stock Titan
Investors brace for Bio-Techne earnings amid muted outlook By Investing.com - Investing.com Canada
Bio-Techne sets 8 a.m. May 6 webcast for fiscal Q3 results - Stock Titan
Bio-Techne CEO Kim Kelderman to speak at BofA healthcare event - Stock Titan
Bio-Techne to Present at the Bank of America Securities 2026 Global Healthcare Conference - ChartMill
Bio-Techne Corp (TECH) Stock Analysis: Evaluating a 31.36% Potential Upside in the Biotechnology Sector - DirectorsTalk Interviews
MSN Money - MSN
Vanguard Group Inc. Sells 121,495 Shares of Bio-Techne Corp $TECH - MarketBeat
UBS Group AG Raises Position in Bio-Techne Corp $TECH - MarketBeat
Conestoga Capital Advisors LLC Boosts Stock Holdings in Bio-Techne Corp $TECH - MarketBeat
Comerica Bank Increases Position in Bio-Techne Corp $TECH - MarketBeat
Bio-Techne Corp. stock underperforms Thursday when compared to competitors - MSN
Understanding the Setup: (TECH) and Scalable Risk - Stock Traders Daily
Bio-Techne Corp. stock underperforms Wednesday when compared to competitors - MarketWatch
Vanguard (NASDAQ: TECH) holds 7.38% stake — 11.56M shares reported - Stock Titan
Bio-Techne's Q3 Earnings on Deck: What's in Store for the Stock? - Yahoo Finance
Bio-Techne (TECH) Expected to Announce Earnings on Wednesday - MarketBeat
Is There Now An Opportunity In Bio-Techne (TECH) After Recent Share Price Weakness - simplywall.st
Bio-Techne Corp. stock underperforms Tuesday when compared to competitors - MarketWatch
M&T Bank Corp Buys 70,496 Shares of Bio-Techne Corp $TECH - MarketBeat
Bio-Techne Corp (TECH) Stock Analysis: Exploring a 33% Potential Upside in the Biotech Sector - DirectorsTalk Interviews
Impax Asset Management Group plc Invests $11.47 Million in Bio-Techne Corp $TECH - MarketBeat
Bio-Techne (TECH) CEO nets shares after stock option exercise - Stock Titan
[Form 4] BIO-TECHNE Corp Insider Trading Activity - Stock Titan
Bio-Techne Corp. Stock Hits Day Low of $51.13 Amid Price Pressure - Markets Mojo
Bio-Techne to Host Conference Call on May 6, 2026, to Announce Third Quarter Fiscal 2026 Financial Results - Investing News Network
What to expect from Bio-Techne's Q3 2026 earnings report - msn.com
Bio-Techne (NASDAQ:TECH) Stock Price Down 10.3%Time to Sell? - MarketBeat
Bio-Techne Corp. stock outperforms competitors despite losses on the day - MarketWatch
Bio-Techne Corp (TECH) Stock Analysis: Navigating a 22% Potential Upside Amidst Market Dynamics - DirectorsTalk Interviews
Bio-Techne Reorganizes Brand To Link Research Spatial And Diagnostics Workflows - Yahoo Finance
The Technical Signals Behind (TECH) That Institutions Follow - Stock Traders Daily
Revvity, Bio-Techne, Corcept, Supernus Pharmaceuticals, and Phibro Animal Health Shares Skyrocket, What You Need To Know - Yahoo Finance
Arvin Capital Management LP's Bio-Techne Corp(TECH) Holding History - GuruFocus
What to Expect From Bio-Techne's Q3 2026 Earnings Report - Barchart.com
Bio-Techne Introduces Streamlined Brand Architecture to Help Customers Navigate Solutions Faster and With Greater Clarity - Investing News Network
Bio-Techne (TECH) CEO exercises 36,500 options and uses 32,088 shares for taxes - Stock Titan
0.14%
0.48%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):